Raltegravir (Isentress®)
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £3M
- Sector
- HEALTH
- Published
- 14 Mar 2022
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
Geochart for 1 buyers and 1 suppliers
1 buyer
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Merck Sharp & Dohme Hoddesdon
Description
Supply of Raltegravir 400mg tablets and Raltegravir 600mg tablets (Isentress®) to NHS Scotland.
Award Detail
| 1 | Merck Sharp & Dohme (Hoddesdon)
|
Award Criteria
| price | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Legal Justification
The medicine awarded to this framework agreement is, and will remain to be, protected by patent for the duration of the framework agreement.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The total value in Sections II.1.7 and V.2.4 refers to the fifteen (15) months initial period and twelve (12) months extension period. (SC Ref:686487)
Reference
- ocds-h6vhtk-0313b0
- FTS 006864-2022